N. prodotti: 0
Totale ordine: € 0,00
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index
Online ISSN 1827-1650
HYSTEROSCOPY: CURRENT KNOWLEDGE AND FUTURE PERSPECTIVES
Paolo CASADIO 1, Francesca GUASINA 1, Ciro MORRA 1, Maria R. TALAMO 1, Concetta LEGGIERI 1, Jessica FRISONI 2, Renato SERACCHIOLI 1
1 Department of Gynecology and Physiopathology of Reproduction, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy; 2 Department of Experimental, Diagnostic and Speciality Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Bologna, Italy
Even if usually asymptomatic, uterine myomas have been associated with a number of clinical issues such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMB), infertility, recurrent pregnancy loss, especially when these masses are submucous. Golden standard treatment for symptomatic submucous fibroids has long been considered their laparotomic removal or a total hysterectomy. The development of endoscopy has made these fibroids accessible and removable from the inner surface of uterus. Hysteroscopy arose as a diagnostic technique, but then it also became an alternative surgical technique for many diseases, offering therapeutic and irreplaceable possibilities of treatment, avoiding major surgery on the one hand, and allowing the correction of pathologies specifically related to female fertility, on the other hand. Excision by slicing has been described as traditional resectoscopic submucosal myomectomy, but today there are new procedures among which the operator can choose, that allow overcoming the initial limitations of the traditional resectoscopic myomectomy in clinical practice.